Skip to main content

FDA Updates

Adcetris plus Chemotherapy Now FDA Approved for Pediatric Patients with Classical Hodgkin Lymphoma

Libtayo plus Platinum-Based Chemotherapy Now FDA Approved for NSCLC without Genomic Aberrations

Lytgobi FDA Approved for Intrahepatic Cholangiocarcinoma with FGFR2 Fusion

Vegzelma a New Biosimilar FDA Approved for the Treatment of 6 Types of Cancer

Pedmark First Drug Approved for Hearing Loss Prevention in Children with Solid Tumors

Retevmo Receives New FDA Indication for Advanced Solid Tumors with RET Fusion

Imfinzi Receives New FDA Indication for Advanced or Metastatic Biliary Tract Cancer

Pemazyre Receives New Indication for FGFR1-Positive Myeloid/Lymphoid Neoplasms

Imbruvica Now Also Indicated for Children with Chronic Graft-versus-Host Disease

Enhertu First FDA-Approved Drug for HER2-Positive Non–Small-Cell Lung Cancer

3
4
5
6
7
8
9

Page 6 of 33
Results 51 - 60 of 330